SCHEMBL396121

SCHEMBL396121

Cc1ccc(O)c(C23CC4CC(CC(C4)C2)C3)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
GFER P55789 1/20 0.51
RARB P10826 5/20 0.50
RARA P10276 5/20 0.50
RARG P13631 4/20 0.50
TP53 P04637 2/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
ALOX12 P18054 1/20 0.49
MAPK1 P28482 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CNR2 P34972 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606457 0.90 MEN1 (0.45) MEN1KMT2APOLBGAAGFER
SCHEMBL11702433 0.86 CNR2 (0.51) MEN1KMT2APOLBGAAGFER
SCHEMBL10779652 0.86 TRPA1 (0.42) MEN1KMT2APOLBGAAGFER
SCHEMBL3755595 0.81 MEN1 (0.55) MEN1KMT2APOLBGAAGFER
SCHEMBL549446 0.80 MEN1 (0.73) MEN1KMT2APOLBGAAGFER
SCHEMBL19150643 0.80 KMT2A (0.54) MEN1KMT2APOLBRARBRARA
SCHEMBL549445 0.79 MEN1 (0.43) MEN1KMT2APOLBGAAGFER
SCHEMBL23774956 0.79 PTPN11 (0.48) MEN1KMT2APOLBGAAGFER
SCHEMBL31680593 0.79 PTPN11 (0.48) MEN1KMT2APOLBGAAGFER
SCHEMBL26624850 0.79 PTPN11 (0.48) MEN1KMT2APOLBGAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 US claimed
US-6797745-B1 Hot melt inks containing styrene or terpene polymers XEROX CORPORATION 2004-09-28 US claimed
US-20250277066-A1 Substituted Pyridine-2,6-Bis(Phenylenephenolate) Complexes with Enhanced Solubility that are Useful as Catalyst Components for Olefin Polymerization EXXONMOBIL CHEMICAL PATENTS INC (US) 2025-09-04 US disclosed
CN-117980314-A Olefin polymerization catalyst system and polymerization process 诺瓦化学品(国际)股份有限公司 2024-05-03 CN disclosed
CN-113614123-B Transition metal bis (phenoxide) complexes and their use as olefin polymerization catalysts 埃克森美孚化学专利公司 2024-01-23 CN disclosed
WO-2023215694-A1 SUBSTITUTED PYRIDINE-2,6-BIS(PHENYLENEPHENOLATE) COMPLEXES WITH ENHANCED SOLUBILITY THAT ARE USEFUL AS CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-11-09 WO disclosed
US-20230348634-A1 Propylene Polymers Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Homogeneous Process for Production Thereof EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-11-02 US disclosed
EP-4103628-A1 PROPYLENE POLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF ExxonMobil Chemical Patents Inc. (US) 2022-12-21 EP disclosed
CN-115315452-A Propylene polymers obtained using transition metal bis (phenolate) catalyst complexes and homogeneous processes for producing the same 埃克森美孚化学专利公司 2022-11-08 CN disclosed
US-11254763-B2 Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-02-22 US disclosed
US-6211370-B1 REACTING A DIENOPHILE WITH A 1,3-DIENE HARVARD UNIVERSITY 2001-04-03 US disclosed
EP-1052967-A2 ANTIPLAQUE ORAL COMPOSITION AND METHOD Colgate-Palmolive Company (US) 2000-11-22 EP disclosed
WO-2000050365-A1 ASYMMETRIC CYCLOADDITION REACTIONS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2000-08-31 WO disclosed
CN-1259527-A Olefine polymerization catalyst, and olefine polymerization method therewith MITSUI CHEMICAL IND CO LTD (JP) 2000-07-12 CN disclosed
EP-1013674-A1 Olefin polymerization catalyst and process for olefin polymerization using this catalyst Mitsui Chemicals, Inc. (JP) 2000-06-28 EP disclosed
WO-1999038480-A2 ANTIPLAQUE ORAL COMPOSITION AND METHOD COLGATE-PALMOLIVE COMPANY (US) 1999-08-05 WO disclosed
WO-1999036375-A1 ASYMMETRIC CYCLOADDITION REACTIONS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-07-22 WO disclosed
US-5851513-A Antiplaque oral composition and method COLGATE PALMOLIVE COMPANY (US) 1998-12-22 US disclosed
CN-1117966-A Biphenyl derivatives EISAI CO LTD (JP) 1996-03-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11254763-B2 Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization CCNT1, CCNA1, CCNE2 MEN1 2396/4885KMT2A 772/4885POLB 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.